[Influence of betamethasone on the vascular resistance in human placenta perfused in vitro]. 1989

J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska

The study was carried out on 48 human placentas perfused in vitro. Betamethasone was administered into the arterial system in the following single doses: 0.4 mg, 2 mg, 10 mg. It was found that betamethasone decreases the pressure of perfusion in different ways depending on the dose. A statistically significant decrease in perfusion pressure was observed in 30th minute of the experiment after administering 2 mg while a dose of 10 mg induced a significant perfusion pressure in 30th and 60th minute of the experiment. The relaxation of the blood vessels of the placenta under the influence of betamethasone was attributed to the action of dopamine on the dopaminergic receptors of the vessels and glucocorticoids modifying this action. The results of the experiments point to a positive action of betamethasone on the blood vessels of human placenta.

UI MeSH Term Description Entries
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001623 Betamethasone A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) Betadexamethasone,Flubenisolone,Celeston,Celestona,Celestone,Cellestoderm
D014655 Vascular Resistance The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT. Peripheral Resistance,Total Peripheral Resistance,Pulmonary Vascular Resistance,Systemic Vascular Resistance,Peripheral Resistance, Total,Resistance, Peripheral,Resistance, Pulmonary Vascular,Resistance, Systemic Vascular,Resistance, Total Peripheral,Resistance, Vascular,Vascular Resistance, Pulmonary,Vascular Resistance, Systemic
D015424 Reperfusion Restoration of blood supply to tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. It is primarily a procedure for treating infarction or other ischemia, by enabling viable ischemic tissue to recover, thus limiting further necrosis. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing REPERFUSION INJURY. Reperfusions
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
June 1996, Ginekologia polska,
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
February 1968, Steroids,
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
December 1973, American journal of obstetrics and gynecology,
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
June 1995, Placenta,
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
January 1990, Pediatric research,
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
October 1997, American journal of reproductive immunology (New York, N.Y. : 1989),
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
June 1991, The American journal of physiology,
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
January 1992, Placenta,
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
January 1966, Annales medicinae experimentalis et biologiae Fenniae,
J Kraczkowski, and M Grudzień, and H Zrubek, and J Oleszczuk, and M Samberger, and W Bednarek, and A Billewicz-Kraczkowska
February 1977, American journal of obstetrics and gynecology,
Copied contents to your clipboard!